metformin has been researched along with Carcinoma, Small Cell Lung in 8 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to examine the effect of metformin on the prognosis of patients with SCLC combined with diabetes mellitus (DM)." | 7.88 | Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus. ( Han, N; Huang, Z; Lu, H; Mao, W; Qin, J; Xie, F, 2018) |
| "The aim of this study was to examine the effect of metformin on the prognosis of patients with SCLC combined with diabetes mellitus (DM)." | 3.88 | Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus. ( Han, N; Huang, Z; Lu, H; Mao, W; Qin, J; Xie, F, 2018) |
| "Metformin has been widely used as the treatment of type II diabetes mellitus for its anti-hyperglycemic effect." | 1.62 | Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC). ( Chae, YK; Cho, S; Choi, H; Choi, J; Gim, G; Kang, CY; Kim, L; Kim, Y; Lee, JY; Park, I; Vagia, E; Viveiros, P, 2021) |
| "Metformin use was associated with improved survival, especially LCSS in patients with regional stage SCC." | 1.62 | Metformin use and lung cancer survival: a population-based study in Norway. ( Botteri, E; Brancher, S; Damhuis, RAM; Johannesen, TB; Strand, TE; Støer, NC; Weiderpass, E, 2021) |
| "The metformin was used in 120 (46." | 1.42 | Metformin use improves the survival of diabetic combined small-cell lung cancer patients. ( Chen, L; Gao, F; Jia, Y; Kong, F; Li, X; Liu, G; Liu, H; Yu, J; Zheng, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, Y | 1 |
| Vagia, E | 1 |
| Viveiros, P | 1 |
| Kang, CY | 1 |
| Lee, JY | 1 |
| Gim, G | 1 |
| Cho, S | 1 |
| Choi, H | 1 |
| Kim, L | 1 |
| Park, I | 1 |
| Choi, J | 1 |
| Chae, YK | 1 |
| Brancher, S | 1 |
| Støer, NC | 1 |
| Weiderpass, E | 1 |
| Damhuis, RAM | 1 |
| Johannesen, TB | 1 |
| Botteri, E | 1 |
| Strand, TE | 1 |
| Fan, H | 1 |
| Bai, S | 1 |
| Guan, X | 1 |
| Ma, W | 1 |
| Fu, Y | 1 |
| Zhang, X | 1 |
| Deng, L | 1 |
| Tian, J | 1 |
| Lu, H | 1 |
| Xie, F | 1 |
| Huang, Z | 1 |
| Qin, J | 1 |
| Han, N | 1 |
| Mao, W | 1 |
| Zeng, S | 1 |
| Gan, HX | 1 |
| Xu, JX | 1 |
| Liu, JY | 1 |
| Kong, F | 1 |
| Gao, F | 1 |
| Liu, H | 1 |
| Chen, L | 1 |
| Zheng, R | 1 |
| Yu, J | 1 |
| Li, X | 1 |
| Liu, G | 1 |
| Jia, Y | 1 |
| Xu, T | 1 |
| Liang, G | 1 |
| Yang, L | 1 |
| Zhang, F | 1 |
| Cao, H | 1 |
| Dong, W | 1 |
| Shen, H | 1 |
| Xu, J | 1 |
| Zhu, L | 1 |
| Liu, Q | 1 |
| Du, J | 1 |
2 reviews available for metformin and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Metformin improves survival in patients with concurrent diabetes and small cell lung cancer: a meta-analysis.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lung Neoplasms; Metformin; Small Cell Lung C | 2023 |
Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; China; Confidence Intervals; Diabetes Mellitus, Type 2; Humans | 2019 |
6 other studies available for metformin and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
Topics: Antineoplastic Agents, Immunological; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; | 2021 |
Metformin use and lung cancer survival: a population-based study in Norway.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lu | 2021 |
Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
Topics: China; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lung Neopl | 2018 |
Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Topics: Aged; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Lung Neoplasms; Mal | 2015 |
Prognosis of small cell lung cancer patients with diabetes treated with metformin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Case-Control Studies; Che | 2015 |
Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Arrestins; beta-Arrestins; Cell Line, Tumor; Combined Modality | 2015 |